BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Aniracetam

N-anisoyl-GABA [Supplementary Concept] RN from Toxlit; structure given in first source; metabolite of aniracetam

110+ PubMed studies analyzed · 5 RCTs · Evidence Score: 45.3

Research Domains

Aniracetam has been studied across 16 research domains including 🧠 Cognitive, 🧠 Memory, 🧠 Learning, 🧠 Focus & Attention, 🧠 Neuroprotection. The primary research focus is 🧠 Cognitive with 53% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Aniracetam, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

rs
4 shared targets
tezampanel
4 shared targets
cyclothiazide
3 shared targets
s
4 shared targets
nbqx
4 shared targets
Piracetam
4 shared targets
perampanel
2 shared targets
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic
4 shared targets
kainic
3 shared targets
Carbon
3 shared targets
Loading evidence profile...

This evidence profile for Aniracetam is generated deterministically from 110 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.